Paid Clinical Trials in Boise, ID
As of July 2026, 233 paid clinical trials are recruiting in Boise, Idaho. Compensation typically covers time, travel, and study visits, with stipends ranging from modest amounts for short outpatient studies to several thousand dollars for long or inpatient protocols.
Boise offers studies at sites including Saint Luke's Cancer Institute - Boise for conditions such as Acute Myeloid Leukemia, ARDS, Acute Respiratory Distress Syndrome, Malignant Solid Neoplasm. Both patients with specific conditions and healthy volunteers can qualify. Most trials offer free study-related medical care alongside compensation.
Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: .
Trials by specialty in Boise
Trials by drug in Boise
Filter results
223 clinical trials
↓ Download CSVStudy of Sacituzumab Govitecan-hziy and Pembrolizumab Versus Treatment of Physician's Choice in Patients With Triple Negative Breast Cancer Who Have Residual Invasive Disease After Surgery and Neoadjuvant Therapy (ASCENT-05/AFT-65 OptimICE-RD/GBG 119/NSABP B-63)
MILD® Percutaneous Image-Guided Lumbar Decompression: A Medicare Claims Study
Trial Against INtractable Type 2 Diabetes (CAPTAIN-T2D)
A Study of Donanemab (LY3002813) in Participants Who Completed Study AACM (TRAILBLAZER-ALZ 3-EXT).
A Study to Evaluate the Optimization of the Cytokine Release Syndrome Profile for Glofitamab in Combination With Gemcitabine Plus Oxaliplatin in Participants With Relapsed/Refractory Aggressive B-Cell Non-Hodgkin's Lymphoma
A Study to Learn About a Study Medicine Called Ibuzatrelvir in Adult and Adolescent Patients With COVID-19 Who Are Not Hospitalized But Are at Risk For Severe Disease
A Clinical Study of Molnupiravir to Prevent Severe Illness From Coronavirus Disease 2019 (COVID-19) in People Who Are High Risk (MK-4482-023)
A Study to Evaluate the Efficacy and Safety of Standard-of-Care Chemotherapy and Bevacizumab With or Without INCA33890 in the First-Line Treatment of Metastatic Microsatellite Stable Colorectal Cancer
Cadisegliatin as Adjunctive Therapy to Insulin in Participants With Type 1 Diabetes
A Study of Mezagitamab in Adults With Kidney Condition Called IgA Nephropathy
A Study to Evaluate the Safety and Efficacy of Ruxolitinib Cream in Pediatric Participants With Nonsegmental Vitiligo
A Randomized Study of Azetukalner Versus Placebo in Major Depressive Disorder
A Study of Upadacitinib in Adult Participants With Moderate-to-Severe Atopic Dermatitis and Inadequate Response to Dupilumab
BEATRIX: A Study to Learn About a Group B Streptococcus Vaccine in Healthy Pregnant Women and Their Babies
A Study of Vepugratinib (LY3866288) in Participants With Cancer in the Urinary Tract
A Phase 3 Study of Revaccination in Subsequent Pregnancies With Bivalent RSV Vaccine and Duration of Protection of a Single Dose
A Study to Assess Change in Disease Activity and Adverse Events of Oral Upadacitinib in Adult and Adolescent Participants With Moderate to Severe Hidradenitis Suppurativa Who Have Failed Anti-TNF Therapy
LY4268989 in Adults With Moderately to Severely Active Ulcerative Colitis
A Study of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) as Monotherapy and in Combination With Pembrolizumab (MK-3475) in Participants With Triple-Negative Breast Cancer (MK-2870-011/TroFuse-011)
A Study to Learn About the Study Medicine Ibuzatrelvir in Adults With COVID-19 Who Are Severely Immunocompromised
Efficacy and Safety Study of Rimegepant for the Preventative Treatment of Migraine in Pediatric Subjects
A Study to Learn About How a New Pneumococcal Vaccine Works in Infants.
Study of Targeted Therapies for the Treatment of Adult Participants With Moderate to Severe Crohn's Disease
A Study Evaluating the Efficacy and Safety of Divarasib and Pembrolizumab Versus Pembrolizumab and Pemetrexed and Carboplatin or Cisplatin in Participants With Previously Untreated, KRAS G12C-Mutated, Advanced or Metastatic Non-Squamous Non-Small Cell Lung Cancer
Proact: A Study of REACT in Subjects With Type 2 Diabetes Mellitus and Chronic Kidney Disease
A Study to Determine if BHV-7000 is Effective and Safe in Adults With Refractory Focal Onset Epilepsy
BradycArdia paCemaKer With AV Interval Modulation for Blood prEssure treAtmenT
A Trial to Evaluate Intravesical Nadofaragene Firadenovec Alone or in Combination With Chemotherapy or Immunotherapy in Participants With High-grade BCG Unresponsive Non-muscle Invasive Bladder Cancer
A Study to Customize Ibrutinib Treatment Regimens for Participants With Previously Untreated Chronic Lymphocytic Leukemia
Study to Evaluate the Efficacy and Safety of Deuruxolitinib in Adolescents With Severe Alopecia Areata
Study to Learn About Safety, Tolerability, and Immune Response of a Catch-up Pneumococcal Vaccine in Children and Adolescents
A Study to Evaluate XEN1101 as Adjunctive Therapy in Primary Generalized Tonic-Clonic Seizures
A Study to Investigate Efficacy, Safety and Tolerability of Barzolvolimab Versus Placebo in Adults With Cold Induced Urticaria and Symptomatic Dermographism Inadequately Controlled by H1-antihistamines (EMBARQ - ColdU and SD)
Beamion LUNG-3: Adjuvant Zongertinib vs Standard Treatment in People With Completely Resected Stage II-IIIB NSCLC Harboring Activating HER2 TKD Mutations
A Study Comparing Anitocabtagene Autoleucel to Standard of Care Therapy in Participants With Relapsed/ Refractory Multiple Myeloma
ANCHOR Study: A Study to Assess the Safety and Efficacy of ABBV-CLS-628 in Adult Participants With Autosomal Dominant Polycystic Kidney Disease (ADPKD)
A Study of the Efficacy and Safety of DMX-200 in Patients With FSGS Who Are Receiving an ARB
Study of BLU-808 in Chronic Inducible Urticaria (CIndU) and Chronic Spontaneous Urticaria (CSU)
A Study of Dulaglutide (LY2189265) 3.0 mg and 4.5 mg in Pediatric Participants With Type 2 Diabetes Mellitus (AWARD-PEDS PLUS)
About research studies in Boise
Boise has approximately 233 recruiting research studies across a wide range of therapeutic areas. Idaho hosts a diverse network of universities, academic medical centers, and community hospitals that run clinical trials across oncology, cardiology, neurology, and many other therapeutic areas.
Top Research Study Locations in Boise
Researchers run research studies in Boise, ID at 25 active sites. The clinics below currently host the largest number of recruiting studies — each name is followed by the conditions they focus on most.
| Site | Specializes in | Active trials |
|---|---|---|
| Saint Luke's Cancer Institute - Boise | Acute Myeloid Leukemia, Malignant Solid Neoplasm, Anatomic Stage II Breast Cancer AJCC v8 | 88 |
| Saint Alphonsus Cancer Care Center-Boise | Acute Myeloid Leukemia, Stage IV Lung Cancer AJCC v8, Malignant Solid Neoplasm | 71 |
| Treasure Valley Medical Research | Chronic Inducible Urticaria, Chronic Spontaneous Urticaria, Atopic Dermatitis | 8 |
| St. Luke's Boise Medical Center | ARDS, ARDS (Acute Respiratory Distress Syndrome), Acute Respiratory Distress Syndrome | 7 |
| Boise VA Medical Center | Chronic Obstructive Pulmonary Disease, HIV, Inhaled Corticosteroid | 4 |
| Saint Alphonsus Regional Medical Center | Amyotrophic Lateral Sclerosis, RSV Infection | 4 |
| Advanced Specialty Research | Healthy, Idiopathic Overactive Bladder, Idiopathic Overactive Bladder With Urinary Incontinence | 3 |
| Consultants in Epilepsy and Neurology, PLLC | Epilepsy, Focal Epilepsy, Focal Onset Seizure | 3 |
| St. Luke's Cancer Institute | Colorectal Adenocarcinoma, KRAS G12C Lung Cancer, Multiple Myeloma | 3 |
| ASR, LLC | Pneumococcal Disease, Alopecia Areata | 3 |
| St. Luke's Cancer Institute: Boise | Carcinoma, Transitional Cell, Metastatic Non-small Cell Lung Cancer With MTAP Deletion, Neoplasm Metastasis | 3 |
| Ascendis Investigational Site | Growth Hormone Deficiency | 2 |
| Boise VA Medical Center, Boise, ID | BARD1, BRCA1, BRCA2, BRIP1, CHEK1, FANCL, PALB2, Chronic Pain, Metastatic Castrate Resistant Prostate Cancer | 2 |
| CARE Institute - Boise Kidney | CKD, Kidney Disease, Metabolic Acidosis | 2 |
| Consultants in Epilepsy & Neurology, PLLC | Focal Epilepsy | 2 |
| Northwest Clinical Trials, Inc. | Actinic Keratosis, Migraine | 2 |
| Saint Alphonsus Regional Medical Center - Boise | Atrial Fibrillation, Intracerebral Hemorrhage, Non-small Cell Lung Cancer | 2 |
| Saint Luke's Cystic Fibrosis Center of Idaho | Cystic Fibrosis, Cystic Fibrosis Pulmonary Exacerbation | 2 |
| St. Alphonsus Regional Medical Center | Aortic Stenosis, Brain Tumor, Brain Tumor - Metastatic | 2 |
| St. Luke's Children's Endocrinology | Idiopathic Short Stature | 2 |
| St. Luke's Children's Endocrinology and Diabetes | Noonan Syndrome, Type 2 Diabetes | 2 |
| Boise | Heart Failure With Preserved Ejection Fraction, Pulmonary Hypertension | 1 |
| Boise Kidney | FSGS | 1 |
| Boise Kidney and Hypertension PLLC | Chronic Kidney Diseases, Type 2 Diabetes Mellitus | 1 |
| Boise State University | Distress, Emotional | 1 |
Active & Upcoming Studies in Boise (2026)
Recruiting trials in Boise grouped by therapeutic area, drawn from ClinicalTrials.gov. Each bucket shows the most recent example studies.
Cancer & tumors (112 active studies)
- Studying Chemotherapy With or Without Panitumumab for Unresectable, Locally Advanced, or Metastatic Pancreatic Cancer Without KRAS Mutations · Phase 3 · SWOG Cancer Research Network
- Testing the Addition of Anti-Cancer Drug Sonrotoclax, to the Standard Treatment Zanubrutinib, for Previously Untreated CLL/SLL · Phase 3 · Alliance for Clinical Trials in Oncology
Neurology & pain (11 active studies)
- A Study of Donanemab (LY3002813) in Participants Who Completed Study AACM (TRAILBLAZER-ALZ 3-EXT). · Phase 3 · Eli Lilly and Company
- A Long-term Study of the Safety and Effectiveness of RAP-219 in Adults With Focal Onset Seizures · Phase 2 · Rapport Therapeutics Inc.
Cardiovascular (10 active studies)
- A Global Study Comparing Pulsed Field Ablation With Electrographic Flow Mapping Versus Posterior Wall Ablation for Persistent Atrial Fibrillation · Boston Scientific Corporation
- Repeat Ablation of Persistent Atrial Fibrillation, Including Mitral Isthmus Catheter Ablation, With the FARAPULSE Pulsed Field Ablation System · Boston Scientific Corporation
Diabetes & metabolic (7 active studies)
- Trial Against INtractable Type 2 Diabetes (CAPTAIN-T2D) · Phase 2 · Sparrow Pharmaceuticals
- A Study to Investigate Efficacy and Safety of Teplizumab Compared With Placebo in Participants 1 to 25 Years of Age With Stage 3 Type 1 Diabetes · Phase 3 · Sanofi
Vaccines (5 active studies)
Mental health & behavior (3 active studies)
- Optimizing Medications and Lung Health in People With HIV Through Pharmacist-led Proactive E-Consults · Seattle Institute for Biomedical and Clinical Research
- Veterans' Cognitive Function, Mental Health, and Quality of Life After Hyperbaric Oxygen Therapy · Phase 2 · Summit Hyperbarics and Wellness
HIV / STI (1 active study)
- Optimizing Medications and Lung Health in People With HIV Through Pharmacist-led Proactive E-Consults · Seattle Institute for Biomedical and Clinical Research
Common conditions studied in Boise
- Acute Myeloid Leukemia (8 active studies). Leukemia trials evaluate targeted inhibitors, CAR-T cell therapies, and novel combinations for acute and chronic forms of the disease.
- ARDS (5 active studies). Recruiting ARDS studies evaluate investigational treatments, diagnostics, and supportive care approaches to improve patient outcomes.
- Acute Respiratory Distress Syndrome (5 active studies). Recruiting Acute Respiratory Distress Syndrome studies evaluate investigational treatments, diagnostics, and supportive care approaches to improve patient outcomes.
- Malignant Solid Neoplasm (5 active studies). Recruiting Malignant Solid Neoplasm studies evaluate investigational treatments, diagnostics, and supportive care approaches to improve patient outcomes.
- Stage IIIB Lung Cancer AJCC v8 (5 active studies). Lung cancer research focuses on targeted therapies for specific mutations such as EGFR, ALK, and KRAS, alongside immunotherapy regimens.
- Stage IV Lung Cancer AJCC v8 (5 active studies). Lung cancer research focuses on targeted therapies for specific mutations such as EGFR, ALK, and KRAS, alongside immunotherapy regimens.
Leading research sponsors in Boise
- National Cancer Institute (NCI)
- Alliance for Clinical Trials in Oncology
- SWOG Cancer Research Network
- Children's Oncology Group
- ECOG-ACRIN Cancer Research Group
Local regulations and guidelines
Clinical trials in Idaho are governed by U.S. Food and Drug Administration (FDA) regulations, Office for Human Research Protections (OHRP) standards, and federal HIPAA privacy rules. Every study is reviewed by an Institutional Review Board (IRB) to protect participant safety and ensure informed consent. Idaho research additionally follows state public health department oversight and any applicable state privacy statutes.
Compensation & what to expect
- How payment typically works
- Compensation is most often provided through reloadable electronic study cards or direct deposit, paid out per completed visit rather than as a lump sum. Amounts vary by the time required, the number of visits, and the study's complexity — overnight stays and inpatient pharmacology studies generally pay more than short outpatient surveys. The exact amount is disclosed in writing during informed consent before any visit.
- Healthy volunteers
- Healthy participants aged 18 and older can earn compensation by joining vaccine, pharmacology, and biomarker studies in Boise. These trials check how a new drug or vaccine behaves in healthy bodies before later-phase testing. Many sites maintain a healthy-volunteer registry so you hear about new opportunities first.
- What's included beyond payment
- Most trials cover study-related medical care at no cost — physical exams, lab work, imaging, the investigational treatment itself, and follow-up visits with the research team. Insurance is not required to participate. Free check-ups and access to specialists are common reasons participants return for additional studies.
- Travel and time
- Many sponsors reimburse travel, parking, mileage, and lost wages for visit days. Long-running studies and trials that require frequent visits often raise stipends accordingly. Ask the study coordinator for the visit schedule and reimbursement policy before you commit.
- Asking about compensation
- Compensation is set per protocol and per site, so figures are not published in trial registries. The fastest way to confirm payment for a specific study is to contact the recruiting site listed on the study record. Coordinators are accustomed to this question and will quote the per-visit and total amounts up front.
How to find a clinical trial in Boise
Hipa.ai aggregates every recruiting study in Boise from ClinicalTrials.gov and refreshes the list daily. Use the filters above to narrow by condition, facility, age, phase, or healthy-volunteer eligibility, then click any study title to view full details — eligibility criteria, intervention, location, and sponsor contact information. To enroll, reach out to the central study contact listed on the study detail page; the research coordinator will walk you through the screening process.
Frequently asked questions
How many paid clinical trials are currently recruiting in Boise?
There are approximately 233 recruiting clinical trials in Boise, Idaho listed on ClinicalTrials.gov. The number changes weekly as new studies open and others close enrollment.
Do clinical trials in Boise pay participants?
Most recruiting trials in Boise compensate participants for their time, travel, and study visits. Compensation varies by sponsor, study phase, and visit requirements — the exact amount is disclosed by the study team during the informed consent process.
Who can participate in a clinical trial in Boise?
Eligibility depends on the specific study. Each trial defines its own inclusion criteria (age, diagnosis, medical history, prior treatments) and exclusion criteria. Both patients with specific conditions and healthy volunteers can qualify, depending on the study design.
What conditions are most commonly studied in Boise?
The most common conditions under active study in Boise include Acute Myeloid Leukemia (8), ARDS (5), Acute Respiratory Distress Syndrome (5), Malignant Solid Neoplasm (5), among many others. Browse the list above to explore every recruiting trial.
Are there clinical trials for healthy volunteers in Boise?
Yes. Healthy-volunteer studies — often early-phase pharmacology or vaccine trials — recruit in Boise on an ongoing basis. Use the "Healthy volunteers only" filter above to view trials that accept participants without the study's target condition.
How do I enroll in a clinical trial in Boise?
Click any study title above to see the full study record, including eligibility criteria, visit schedule, and the study team's contact information. Reach out to the central contact or recruiting site directly — they will guide you through screening and informed consent.
Where can I take part in paid clinical trials in Boise?
Recruiting research sites in Boise include Saint Luke's Cancer Institute - Boise, Saint Alphonsus Cancer Care Center-Boise, Treasure Valley Medical Research, among others. Each site lists its open studies and contact information on the study record above — call or email the site coordinator to ask about screening for a specific protocol.
What kinds of studies are recruiting in Boise right now?
The largest active categories in Boise are Cancer & tumors (112), Neurology & pain (11), Cardiovascular (10). Use the filters above to narrow by therapeutic area, phase, age, or healthy-volunteer eligibility.